Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Therapeutic Advances for the Management of Pediatric Patients with Atopic Dermatitis

Program Overview

This continuing medical education program is derived from material presented in an AcademicCME-sponsored symposium held in conjunction with the 2020 AAP Virtual National Conference & Exhibition. This continuing medical education program will highlight therapeutic advances for the management of patients with atopic dermatitis, focusing primarily on the pediatric population. The expert faculty, chaired by Dr. Lawrence F. Eichenfield, ...
View Course
The Science and Guidelines Concerning COVID-19 and Biosimilar Therapeutics for Inflammatory Conditions

Program Overview

In this module, Rowena Schwartz PharmD, BCOP, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair, will provide current data for treating patients with biosimilars in the era of the COVID-19 pandemic. The expert faculty will highlight the evolving impact of COVID-19 on healthcare expenditure, including availability of services and financial burdens. Therapeutic considerations amidst the pandemic ...
View Course
Incorporating Biosimilars into Treatment Plans for Inflammatory Rheumatological Disorders

Program Overview

In this module, Jonathan Kay, MD, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair and Francis A. Farraye, MD, MSc, will review current clinical trial data, including registry data, of biosimilar therapeutics in patients with rheumatological disorders. The expert faculty will analyze recent studies, debating the clinical implications of each. Terms such as biosimilarity, changing and ...
View Course
Incorporating Biosimilars into Treatment Plans for Inflammatory Gastroenterological Disorders

Program Overview

In this module, Francis A. Farraye, MD, MSc, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair and Jonathan Kay, MD, will analyze current clinical trial of data of biosimilar agents, particularly in gastroenterological disorders. Efficacy and immunogenicity in both induction and switching studies will be reviewed, and clinical relevance debated. The expert faculty will also relay ...
View Course
Patient Education and Shared Decision-Making Specific to Biosimilar Therapeutics: The Why and The How

Program Overview

In this module, Amy Goodrich, RN, BSN, MSN, CRNP-AC, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair, will highlight best practices for shared decision making as well as strategies for administering comprehensive patient education to promote adherence to biosimilar agents. The expert faculty will review methods to minimize the ‘nocebo’ effect and improve outcomes in patients ...
View Course
Biosimilars 101: The Science, Approval Process, and Extrapolation of Clinical Data and Indications

Program Overview

In this module, Ali McBride, PharmD, MS, BCPS, BCOP, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair, will provide background information regarding the science and approval process of biosimilar agents in inflammatory conditions. Topics such as immunogenicity and the extrapolation framework will also be reviewed in a discussion-based format. At the conclusion of this 30-minute interview ...
View Course

Upcoming Events

2021 Joint Pre-ECTRIMS Online Workshop

October 11th – 12th, 2021

CME/CE Symposium at the Congress of Clinical Rheumatology West Meeting

September 19th, 2021

2021 Consortium of Multiple Sclerosis Centers Annual Meeting

October 25th – 28th, 2021

Advanced Curriculum for Multiple Sclerosis 2022

February 22nd, 2022